Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project

• Published in: Neuropsychopharmacology reports Vol. 40; no. 3; pp. 281 - 286
• Main Authors: Ichihashi, Kayo, Hori, Hikaru, Hasegawa, Naomi, Yasuda, Yuka, Yamamoto, Tomoya, Tsuboi, Takashi, Iwamoto, Kunihiro, Kishimoto, Taishiro, Horai, Tadasu, Yamada, Hiroki, Sugiyama, Nobuhiro, Nakamura, Toshinori, Tsujino, Naohisa, Nemoto, Kiyotaka, Oishi, Satoru, Usami, Masahide, Katsumoto, Eiichi, Yamamori, Hidenaga, Tomita, Hiroaki, Suwa, Taro, Furihata, Ryuji, Inagaki, Takahiko, Fujita, Junichi, Onitsuka, Toshiaki, Miura, Kenichiro, Matsumoto, Junya, Ohi, Kazutaka, Matsui, Yuki, Takaesu, Yoshikazu, Hashimoto, Naoki, Iga, Junichi, Ogasawara, Kazuyoshi, Yamada, Hisashi, Watanabe, Koichiro, Inada, Ken, Hashimoto, Ryota
• Format: Journal Article
• Language: English
• Published: Hoboken John Wiley & Sons, Inc 01.09.2020; John Wiley and Sons Inc; Wiley
• Subjects: Antidepressants; Antipsychotics; Conflicts of interest; Data analysis; Data collection; Drug dosages; Education; EGUIDE project; Electroconvulsive therapy; guideline; Medical practices; Micro Report; Micro Reports; Polypharmacy; Prescription drugs; Psychotropic drugs; Quality control; quality indicator; Schizophrenia; Standard deviation; Japan
• ISSN: 2574-173X; 2574-173X
• DOI: 10.1002/npr2.12122

Background Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. “Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)” project aimed to standardize medical practice using quality indicators (QIs) as indices to evaluate the quality of medical practice. In this study, we have reported the quality indicator values of prescription before the beginning of the guideline lectures in the EGUIDE project to ascertain the baseline status of treating patients with schizophrenia. Methods A cross‐sectional, retrospective case record survey was conducted, involving 1164 patients with schizophrenia at the time of discharge. We checked all types and dosage of psychotropic drugs. Results Forty‐three percent of patients had antipsychotic polypharmacy, and substantial concomitant medication was observed (antidepressants; 8%, mood stabilizers: 37%, anxiolytics or hypnotics: 68%). Conclusions In the results obtained in this study, we plant to report changes in the effectiveness of education in the EGUIDE project near the future. This study reports the prescription pattern in schizophrenia in Japan from EGUIDE (Effectiveness of Guideline for Dissemination and Education in psychiatric treatment) project. A cross‐sectional, case record survey conducted, involving 1164 patients with schizophrenia at the time of discharge. Forty‐three percent of patients received antipsychotic polypharmacy. Based on the results, we plan to report changes in the effectiveness of education in the EGUIDE project in the future.